Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

The Pregnancy Risk Assessment Monitoring System (PRAMS): Overview of Design and Methodology.

Shulman HB, D'Angelo DV, Harrison L, Smith RA, Warner L.

Am J Public Health. 2018 Oct;108(10):1305-1313. doi: 10.2105/AJPH.2018.304563. Epub 2018 Aug 23.

2.

Hepatic veno-occlusive disease following sirolimus-based immune suppression.

Khimani F, McDonald GB, Shulman HM, Betts B, Locke F, Fernandez H, Anasetti C, Pidala J.

Bone Marrow Transplant. 2018 Jun 12. doi: 10.1038/s41409-018-0233-2. [Epub ahead of print]

PMID:
29895929
3.

Incidence and Outcomes of Positive Bubble Contrast Study Results After Transcatheter Closure of a Patent Foramen Ovale.

Shah AH, Osten M, Benson L, Alnasser S, Bach Y, Vishwanath R, Van De Bruaene A, Shulman H, Navaranjan J, Khan R, Horlick E.

JACC Cardiovasc Interv. 2018 Jun 11;11(11):1095-1104. doi: 10.1016/j.jcin.2018.03.008.

PMID:
29880106
4.

Vital Signs: Trends and Disparities in Infant Safe Sleep Practices - United States, 2009-2015.

Bombard JM, Kortsmit K, Warner L, Shapiro-Mendoza CK, Cox S, Kroelinger CD, Parks SE, Dee DL, D'Angelo DV, Smith RA, Burley K, Morrow B, Olson CK, Shulman HB, Harrison L, Cottengim C, Barfield WD.

MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):39-46. doi: 10.15585/mmwr.mm6701e1.

5.

Measures Taken to Prevent Zika Virus Infection During Pregnancy - Puerto Rico, 2016.

D'Angelo DV, Salvesen von Essen B, Lamias MJ, Shulman H, Hernandez-Virella WI, Taraporewalla AJ, Vargas MI, Harrison L, Ellington SR, Soto L, Williams T, Rodriguez A, Shapiro-Mendoza CK, Rivera B, Cox S, Pazol K, Rice ME, Dee DL, Romero L, Lathrop E, Barfield W, Smith RA, Jamieson DJ, Honein MA, Deseda C, Warner L.

MMWR Morb Mortal Wkly Rep. 2017 Jun 9;66(22):574-578. doi: 10.15585/mmwr.mm6622a2.

6.

Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Myerson D, Steinbach G, Gooley TA, Shulman HM.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1573-1579. doi: 10.1016/j.bbmt.2017.05.017. Epub 2017 May 19.

7.

A comparison of small-area hospitalisation rates, estimated morbidity and hospital access.

Shulman H, Birkin M, Clarke GP.

Health Place. 2015 Nov;36:134-44. doi: 10.1016/j.healthplace.2015.10.001. Epub 2015 Nov 2.

8.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.

Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia MH, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM, Martin PJ, Sarantopoulos S, Lee SJ, Flowers ME.

Clin Cancer Res. 2016 Jan 15;22(2):319-27. doi: 10.1158/1078-0432.CCR-15-1443. Epub 2015 Sep 16.

9.

Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.

Kreft A, Mottok A, Mesteri I, Cardona DM, Janin A, Kühl AA, Andrulis M, Brunner A, Shulman HM, Negri G, Tzankov A, Huber E; Gastrointestinal Pathology Group of the German-Austrian-Swiss GvHD Consortium.

Virchows Arch. 2015 Sep;467(3):255-63. doi: 10.1007/s00428-015-1803-y. Epub 2015 Jul 12.

PMID:
26164839
10.

Cutaneous macrophage infiltration in acute GvHD.

Terakura S, Martin PJ, Shulman HM, Storer BE.

Bone Marrow Transplant. 2015 Aug;50(8):1135-7. doi: 10.1038/bmt.2015.114. Epub 2015 May 11. No abstract available.

PMID:
25961771
11.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE.

Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603. doi: 10.1016/j.bbmt.2014.12.031. Epub 2015 Jan 29.

12.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME.

Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.

13.

Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.

Evans AT, Loeb KR, Shulman HM, Hassan S, Qiu WC, Hockenbery DM, Ioannou GN, Chauncey TR, Gretch DR, McDonald GB.

Am J Surg Pathol. 2015 Feb;39(2):212-20. doi: 10.1097/PAS.0000000000000345.

PMID:
25517948
14.

Implementation science and the pregnancy risk assessment monitoring system.

Grigorescu VI, D'Angelo DV, Harrison LL, Taraporewalla AJ, Shulman H, Smith RA.

J Womens Health (Larchmt). 2014 Dec;23(12):989-94. doi: 10.1089/jwh.2014.5047.

15.

Osteopathic graduate medical education: new research standards needed.

Shulman HM, Cooper K, Devine W, Trzeciak M, Burney U, Chan WP, Gomez A, Humpherys J, Safavi H, Yoshida M.

J Am Osteopath Assoc. 2014 May;114(5):336-9. doi: 10.7556/jaoa.2014.068. No abstract available.

PMID:
24777996
16.

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, Mielcarek M, Shulman H, Storb R, Nash RA.

Bone Marrow Transplant. 2014 Jul;49(7):966-71. doi: 10.1038/bmt.2014.69. Epub 2014 Apr 28.

17.

Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review.

Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1008-13. doi: 10.1016/j.bbmt.2014.03.020. Epub 2014 Apr 3.

18.

Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.

Stift J, Baba HA, Huber E, Federmann B, Fischer HP, Schmitt-Graeff A, Baurmann H, Bethge W, Schirmacher P, Wrba F, Greinix H, Fend F, Schwerdtfeger R, Shulman HM, Wolff D, Longerich T; Liver Pathology Group of the German-Austrian-Swiss Working Group on GvHD.

Virchows Arch. 2014 Feb;464(2):175-90. doi: 10.1007/s00428-013-1528-8. Epub 2014 Jan 3.

PMID:
24385287
19.

Ethical considerations when employing fake identities in online social networks for research.

Elovici Y, Fire M, Herzberg A, Shulman H.

Sci Eng Ethics. 2014 Dec;20(4):1027-43. doi: 10.1007/s11948-013-9473-0. Epub 2013 Nov 12.

PMID:
24218141
20.

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP, Sandmaier BM, Sorror M, Stirewalt DL, Wilson WA, Storb R, Appelbaum FR, Gooley T.

Blood. 2012 Aug 16;120(7):1398-408. doi: 10.1182/blood-2012-04-423046. Epub 2012 Jul 5.

21.

Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.

Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM, Shulman H, Goldmuntz E, Mayes M, Parikh CR, Crofford L, Keyes-Elstein L, Furst D, Steen V, Sullivan KM.

Biol Blood Marrow Transplant. 2011 May;17(5):674-81. doi: 10.1016/j.bbmt.2010.08.003. Epub 2010 Aug 11.

22.

Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC.

Biol Blood Marrow Transplant. 2010 Jul;16(7):1005-17. doi: 10.1016/j.bbmt.2010.02.009. Epub 2010 Feb 16.

23.

Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Deeg HJ, Spaulding E, Shulman HM.

Leuk Lymphoma. 2009 Oct;50(10):1566-72. Review.

24.

Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM.

PLoS One. 2009 Jul 9;4(7):e6203. doi: 10.1371/journal.pone.0006203.

25.

Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.

Sakai M, Strasser SI, Shulman HM, McDonald SJ, Schoch HG, McDonald GB.

Bone Marrow Transplant. 2009 Oct;44(7):441-7. doi: 10.1038/bmt.2009.56. Epub 2009 Mar 23.

26.

Risk perceptions of people living with HIV/AIDS: how similarity affects optimistic bias.

Lapinski MK, Rimal RN, Klein KA, Shulman HC.

J Health Psychol. 2009 Mar;14(2):251-7. doi: 10.1177/1359105308100209.

PMID:
19237492
27.

Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.

Bair S, Spaulding E, Parkkinen J, Shulman HM, Lesnikov V, Beauchamp M, Canonne-Hergaux F, Kowdley KV, Deeg HJ.

Blood. 2009 Feb 19;113(8):1841-4. doi: 10.1182/blood-2008-09-178517. Epub 2008 Dec 23.

28.

Pan-Canadian evaluation of irreversible compression ratios ("lossy" compression) for development of national guidelines.

Koff D, Bak P, Brownrigg P, Hosseinzadeh D, Khademi A, Kiss A, Lepanto L, Michalak T, Shulman H, Volkening A.

J Digit Imaging. 2009 Dec;22(6):569-78. doi: 10.1007/s10278-008-9139-7. Epub 2008 Oct 18.

29.

Pericardial rupture with cardiac herniation.

Chughtai T, Chiavaras MM, Sharkey P, Shulman H, Miller HA.

Can J Surg. 2008 Oct;51(5):E101-2. No abstract available.

30.

Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.

Lesnikov V, Gorden N, Fausto N, Spaulding E, Campbell J, Shulman H, Fleming RE, Deeg HJ.

Apoptosis. 2008 Aug;13(8):1005-12. doi: 10.1007/s10495-008-0233-6.

31.

Are needle decompressions for tension pneumothoraces being performed appropriately for appropriate indications?

Netto FA, Shulman H, Rizoli SB, Tremblay LN, Brenneman F, Tien H.

Am J Emerg Med. 2008 Jun;26(5):597-602. doi: 10.1016/j.ajem.2007.08.016. No abstract available.

PMID:
18534291
32.

How can PRAMS survey response rates be improved among American Indian mothers? Data from 10 states.

Kim SY, Tucker M, Danielson M, Johnson CH, Snesrud P, Shulman H.

Matern Child Health J. 2008 Jul;12 Suppl 1:119-25. doi: 10.1007/s10995-008-0334-4. Epub 2008 Mar 19.

PMID:
18350261
33.

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM.

PLoS One. 2008 Jan 16;3(1):e1452. doi: 10.1371/journal.pone.0001452. Erratum in: PLoS ONE. 2008;3(8). doi: 10.1371/annotation/6b021f46-17bd-4ffe-a378-a1b8d24a1398.

34.

Integrating regional and community lung cancer services to improve patient care.

Dahele M, Ung Y, Meharchand J, Shulman H, Zeldin R, Behzadi A, Simone C, Cheng S, Weigensberg C, Sivjee K.

Curr Oncol. 2007 Dec;14(6):234-7.

35.

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.

Chang C, Storer BE, Scott BL, Bryant EM, Shulman HM, Flowers ME, Sandmaier BM, Witherspoon RP, Nash RA, Sanders JE, Bedalov A, Hansen JA, Clurman BE, Storb R, Appelbaum FR, Deeg HJ.

Blood. 2007 Aug 15;110(4):1379-87. Epub 2007 May 8.

36.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst DE.

Blood. 2007 Aug 15;110(4):1388-96. Epub 2007 Apr 23.

37.

An overview of digital compression of medical images: can we use lossy image compression in radiology?

Koff DA, Shulman H.

Can Assoc Radiol J. 2006 Oct;57(4):211-7. Review.

PMID:
17128888
38.

Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.

Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA, Shulman H, Sullivan KM, Lee J, Henstorf G, Storb R, Furst DE.

Arthritis Rheum. 2006 Jun;54(6):1982-6.

39.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME.

Biol Blood Marrow Transplant. 2006 Apr;12(4):375-96.

40.

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers ME, Greinix H, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB; Response Criteria Working Group.

Biol Blood Marrow Transplant. 2006 Mar;12(3):252-66.

41.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E, Holler E, Ferrara J, Shulman H, Lee SJ, Martin P, Filipovich AH, Flowers ME, Weisdorf D, Couriel D, Lachenbruch PA, Mittleman B, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2006 Feb;12(2):126-37.

42.

The Pregnancy Risk Assessment Monitoring System (PRAMS): current methods and evaluation of 2001 response rates.

Shulman HB, Gilbert BC, Msphbrenda CG, Lansky A.

Public Health Rep. 2006 Jan-Feb;121(1):74-83.

43.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB.

Biol Blood Marrow Transplant. 2006 Jan;12(1):31-47.

44.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME.

Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.

45.

Antibody-catalyzed benzoin oxidation as a mechanistic probe for nucleophilic catalysis by an active site lysine.

Sklute G, Oizerowich R, Shulman H, Keinan E.

Chemistry. 2004 May 3;10(9):2159-65.

PMID:
15112204
46.

Risk factors for legal induced abortion-related mortality in the United States.

Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, Atrash HK.

Obstet Gynecol. 2004 Apr;103(4):729-37.

PMID:
15051566
47.

Prevention of Fas-mediated hepatic failure by transferrin.

Lesnikov VA, Lesnikova MP, Shulman HM, Wilson HM, Hockenbery DM, Kocher M, Pierpaoli W, Deeg HJ.

Lab Invest. 2004 Mar;84(3):342-52.

48.

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney DG, Schoch HG, Woolfrey AE, Shulman HM, Storb R, McDonald GB.

Blood. 2004 Jan 1;103(1):78-84. Epub 2003 Sep 11.

49.

Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada.

Grinblat L, Shulman H, Glickman A, Matukas L, Paul N.

Radiology. 2003 Sep;228(3):802-9. Epub 2003 Jul 9.

PMID:
12853655
50.

Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.

Nash RA, Takatu A, Feng Z, Slichter S, Abrams K, Espino G, Gass MJ, Georges GE, McSweeney PA, Shulman HM, Storb R.

Biol Blood Marrow Transplant. 2002;8(7):360-7.

PMID:
12171482

Supplemental Content

Loading ...
Support Center